| Literature DB >> 25955125 |
James R Nicol1, Dorian Dixon, Jonathan A Coulter.
Abstract
With several gold nanoparticle-based therapies currently undergoing clinical trials, these treatments may soon be in the clinic as novel anticancer agents. Gold nanoparticles are the subject of a wide ranging international research effort with preclinical studies underway for multiple applications including photoablation, diagnostic imaging, radiosensitization and multifunctional drug-delivery vehicles. These applications require an increasingly complex level of surface modification in order to achieve efficacy and limit off-target toxicity. This review will discuss the main obstacles in relation to surface functionalization and the chemical approaches commonly utilized. Finally, we review a range of recent preclinical studies that aim to advance gold nanoparticle treatments toward the clinic.Entities:
Keywords: bottom–up synthesis; gold; nanoparticle; nanoparticle functionalization; nanoparticle stability; organelle targeting
Mesh:
Substances:
Year: 2015 PMID: 25955125 DOI: 10.2217/nnm.14.219
Source DB: PubMed Journal: Nanomedicine (Lond) ISSN: 1743-5889 Impact factor: 5.307